The present invention is directed to methods for preparing intermediates useful in the synthesis of paroxetine wherein the intermediates are substantially free of alkoxy impurities as well as to methods for preparing paroxetine and pharmaceutically acceptable salts thereof substantially free of alkoxy impurities. The alkoxy impurity is reacted with an ether cleaving agent to generate the corresponding phenol, which is separated, yielding the desired product substantially free of alkoxy impurities. Paroxetine intermediates such as PMA, paroxetine, and pharmaceutically acceptable salts thereof substantially free of alkoxy impurities also form part of the present invention.

 
Web www.patentalert.com

< Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes

< Glucagon antagonists/inverse agonists

> Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors

> Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

~ 00201